Will TrumpRx Lower Prescription Drug Prices?
LDI Fellow Argues the Plan Misses Key Drivers of High Costs and Points Instead to Public-Sector Solutions
LDI Fellow Argues the Plan Misses Key Drivers of High Costs and Points Instead to Public-Sector Solutions
Researchers Point to Gains in Access to Care but Declines in Patient Retention and Ongoing Concerns about Quality
LDI Fellows’ Research Quantifies the Effects of High Health Care Costs for Consumers and Shines Light on Several Drivers of High U.S. Health Care Costs
Chart of the Day: $2.6 Trillion From Publicly Traded Companies Went to Dividends and Stock Buybacks, LDI Study Shows
In The Media HealthLeaders Media
Interview
In The Media USA Today
Interview